Solutions
- - Healthcare Professionals
  - - H1 Connect
      
      Connecting Doctors and NGOs to empower medical missions and humanitarian work worldwide.
      
      Learn more
How We Help
- - By Customer
  - Pharmaceutical & Biotechnology
  - Payors
  - Healthcare Professionals
- - Featured
  - - Harnessing Digital Tools for Enhanced HCP Engagement
      
      In Conversation with Kristin Cova, PharmD, Director of Medical Science Liaisons, Ferring Pharmaceuticals
      
      Learn More
Customers
Resources
Company
- - What’s New
  - Press
  - Events
  - Get in Touch
  - Contact Us
- - Featured Press
  - - H1 Launches New Solution Empowering Doctors to Find Global Health Opportunities
      
      Learn More
Request a Demo
Login

Request a Demo Login

Blog

Read the latest perspectives from our team of subject matter experts and others

doctor speaking with patient

FDA Poised to Make Impact on Underrepresented Populations in Clinical Studies

Diversity Action Plans (DAPs) aim to improve data that the FDA receives by increasing the clinical enrollment of historically underrepresented participants. Increasing diversity in clinical trials not only makes the… Continue reading →

Read the article

Post Topics:

Artificial Intelligence

Commercialization

Diversity & Inclusion

Drug Development

Global Impact

HCP Volunteers

KOL Engagement

Provider Data

Research

Post Industries:

Commercialization

Global Impact

Payors

Pharmaceutical & Biotechnology

Provider Data

Research

Artificial Intelligence KOL Engagement Provider Data
A Holistic Approach to Measuring Impact
Medical Affairs plays an essential role in evidence-based medicine, disease education, and driving better outcomes. Their knowledge is crucial as medications become more specialized and complex. They enable healthcare… Continue reading →

Read the article
no
Artificial Intelligence Commercialization Diversity & Inclusion Drug Development KOL Engagement Provider Data Research
Trials, Data, Diversity – H1’s Top 5 Diagnoses (Predictions) for Biotech and Pharma in 2024
How will AI impact clinical trials? Will FDA legislation improve diversity? What platforms will key opinion leaders adopt? Every year, we take a look at annual predictions to help life… Continue reading →

Read the article
no
Artificial Intelligence Commercialization Drug Development
Six Possible Implications of Biden’s Executive Order on AI for Life Sciences
The life sciences sector stands on the brink of a new era marked by the confluence of artificial intelligence (AI) and biomedicine. With President Biden’s recent Executive Order on AI,… Continue reading →

Read the article
no
Artificial Intelligence
Evaluating an AI Product in Life Sciences
The life sciences industry, characterized by stringent regulations, vast data sets, and the critical nature of its decisions, is increasingly turning to Artificial Intelligence (AI) for solutions. AI has the… Continue reading →

Read the article
no
Artificial Intelligence Drug Development
4 AI predictions for the Life Sciences Sector by 2025
The application of AI in the life sciences sector has the potential to revolutionize many aspects of research, development, and patient care. By 2025, we can anticipate pretty significant shifts… Continue reading →

Read the article
no
Artificial Intelligence Commercialization Diversity & Inclusion Drug Development
7 Ways of Generating AI-produced ROI for Life Sciences
For life sciences companies, the application of AI has the potential to provide transformative value, not only in terms of direct financial return but also through operational, research, and clinical… Continue reading →

Read the article
no
Artificial Intelligence
AI for Hire: 5 Considerations for AI Innovation Workforce Strategies
At every industry conference this fall, half of the sessions will likely be focused on artificial intelligence (AI) and how important it is. The challenge is in knowing how AI… Continue reading →

Read the article
no
Artificial Intelligence
The Technology Conundrum
“Technology is a tool. How it’s applied is up to us.” – Wendell Wallach As human beings, our daily decisions impact the lives of others. To guide these decisions,… Continue reading →

Read the article
no
Artificial Intelligence
The Power of Data: Three Ways to Rethink AI Hallucinations
In this new content series, H1’s Senior Director of Strategic Commercial Engagement, Robert Consalvo, writes about leveraging generative AI for business, digital health, life sciences, biotech and pharma and the… Continue reading →

Read the article
no
Artificial Intelligence
Balancing Creativity and Accuracy in Artificial Intelligence
In the realm of AI, balancing creativity and accuracy is a critical consideration, especially when developing AI systems for business applications. While creativity adds novelty and innovation to outputs,… Continue reading →

Read the article
no
Artificial Intelligence KOL Engagement
AI and the MSL Evolution: What Time Has Taught Us
I recently had the chance to deliver the keynote address at the 2022 MSL Society Conference in Las Vegas. It’s been a transformative year for pharma and life sciences, specifically… Continue reading →

Read the article
Artificial Intelligence KOL Engagement
5 Ways Artificial Intelligence Will Benefit Medical Science Liaisons
By now, pretty much everybody agrees that artificial intelligence (AI) will change all of our lives forever. From transportation to quality control, from education to medicine, from entertainment to manufacturing,… Continue reading →

Read the article

Creating a
Healthier Future

Platform

H1

Products

HCP Universe
Trial Landscape
Precise
H1 Connect

About

About H1
Culture
Press
Events
Join Our Team
Login

Contact

Contact Us
Product Support

Social

Facebook Twitter LinkedIn Instagram

© H1 2024 All Rights Reserved Terms of Use Privacy Policy

Welcome

Choose your account below to login.

HCP Universe
Trial Landscape

Don't have an account? Request a demo.

✕